ATE227582T1 - Chemokin rezeptor antagonist und cyclosporin in kombinationstherapie - Google Patents

Chemokin rezeptor antagonist und cyclosporin in kombinationstherapie

Info

Publication number
ATE227582T1
ATE227582T1 AT99948760T AT99948760T ATE227582T1 AT E227582 T1 ATE227582 T1 AT E227582T1 AT 99948760 T AT99948760 T AT 99948760T AT 99948760 T AT99948760 T AT 99948760T AT E227582 T1 ATE227582 T1 AT E227582T1
Authority
AT
Austria
Prior art keywords
cyclosporin
receptor antagonist
combination therapy
chemokine receptor
chemokine
Prior art date
Application number
AT99948760T
Other languages
English (en)
Inventor
Hermann-Joseph Grone
Peter J Nelson
Amanda Proudfoot
Timothy N C Wells
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Application granted granted Critical
Publication of ATE227582T1 publication Critical patent/ATE227582T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/521Chemokines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT99948760T 1998-09-18 1999-09-16 Chemokin rezeptor antagonist und cyclosporin in kombinationstherapie ATE227582T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98117697A EP1000626A1 (de) 1998-09-18 1998-09-18 Kombination von chemokin-rezeptor antagonisten und cyclosporin zur therapie
PCT/EP1999/006844 WO2000016796A1 (en) 1998-09-18 1999-09-16 Chemokine receptor antagonist and cyclosporin in combined therapy

Publications (1)

Publication Number Publication Date
ATE227582T1 true ATE227582T1 (de) 2002-11-15

Family

ID=8232654

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99948760T ATE227582T1 (de) 1998-09-18 1999-09-16 Chemokin rezeptor antagonist und cyclosporin in kombinationstherapie

Country Status (23)

Country Link
US (1) US6902728B1 (de)
EP (2) EP1000626A1 (de)
JP (1) JP2003519082A (de)
KR (1) KR100613950B1 (de)
CN (1) CN1177613C (de)
AR (1) AR021810A1 (de)
AT (1) ATE227582T1 (de)
AU (1) AU766595B2 (de)
BR (1) BR9913846A (de)
CA (1) CA2344370A1 (de)
DE (1) DE69903964T2 (de)
DK (1) DK1113811T3 (de)
EA (1) EA003181B1 (de)
EE (1) EE04705B1 (de)
ES (1) ES2186411T3 (de)
HK (1) HK1041225B (de)
IL (2) IL141899A0 (de)
NO (1) NO20011371L (de)
PT (1) PT1113811E (de)
SI (1) SI1113811T1 (de)
UA (1) UA60379C2 (de)
WO (1) WO2000016796A1 (de)
ZA (1) ZA200101909B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7259136B2 (en) 1999-04-30 2007-08-21 Amylin Pharmaceuticals, Inc. Compositions and methods for treating peripheral vascular disease
US6740636B2 (en) 2000-07-31 2004-05-25 Schering Aktiengesellschaft Non-peptide CCR1 receptor antagonists in combination with cyclosporin A for the treatment of heart transplant rejection
LT5132B (lt) 2000-07-31 2004-05-25 Schering Aktiengesellschaft Nepeptidiniai ccr1 receptorių antagonistai derinyje su ciklosporinu a širdies transplanto atmetimui gydyti
ES2453592T3 (es) 2007-08-02 2014-04-08 Novimmune Sa Anticuerpos anti-RANTES y métodos de uso de los mismos
JP6733968B2 (ja) * 2015-08-31 2020-08-05 日立化成株式会社 腎移植後合併症を評価するための分子法
DE112016003948T5 (de) 2015-08-31 2018-05-09 City Of Sapporo Molekulare verfahren zum beurteilen einer urothelialen erkrankung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI972433A0 (fi) * 1994-12-08 1997-06-06 Glaxo Group Ltd Rantes-peptidi ja fragmentteja sekä tätä sisältäviä tulehduksen hoitoon soveltuvia koostumuksia
CA2228379A1 (en) * 1995-08-09 1997-02-20 Schering Corporation Combined use of interleukin-10 and cyclosporin for immunosuppression therapy
WO1998006703A1 (en) * 1996-08-14 1998-02-19 Warner-Lambert Company 2-phenyl benzimidazole derivatives as mcp-1 antagonists
WO1998006751A1 (en) * 1996-08-16 1998-02-19 Research Corporation Technologies, Inc. Mcp-3, rantes and mip-1alpha receptor antagonists

Also Published As

Publication number Publication date
WO2000016796A1 (en) 2000-03-30
IL141899A (en) 2007-12-03
EE04705B1 (et) 2006-10-16
JP2003519082A (ja) 2003-06-17
CN1177613C (zh) 2004-12-01
EP1113811B1 (de) 2002-11-13
EE200100159A (et) 2002-08-15
PT1113811E (pt) 2003-03-31
CN1319021A (zh) 2001-10-24
HK1041225A1 (en) 2002-07-05
BR9913846A (pt) 2001-06-05
ES2186411T3 (es) 2003-05-01
AU766595B2 (en) 2003-10-16
KR20010075060A (ko) 2001-08-09
EP1113811A1 (de) 2001-07-11
AR021810A1 (es) 2002-08-07
NO20011371D0 (no) 2001-03-16
DE69903964T2 (de) 2003-03-27
EA003181B1 (ru) 2003-02-27
EP1000626A1 (de) 2000-05-17
DE69903964D1 (en) 2002-12-19
KR100613950B1 (ko) 2006-08-18
CA2344370A1 (en) 2000-03-30
US6902728B1 (en) 2005-06-07
DK1113811T3 (da) 2003-03-10
HK1041225B (zh) 2005-04-22
NO20011371L (no) 2001-03-16
AU6191499A (en) 2000-04-10
UA60379C2 (uk) 2003-10-15
IL141899A0 (en) 2002-03-10
ZA200101909B (en) 2001-09-11
SI1113811T1 (en) 2003-04-30
EA200100366A1 (ru) 2001-08-27

Similar Documents

Publication Publication Date Title
NL300395I1 (nl) GnRH antagonisten gemodificeerd in posities 5 en 6
DE69934881D1 (de) Selective il-2 agonisten und antagonisten
DE69932265D1 (de) Musikaktionsspielsystem und computerlesbare Aufzeichnungsvorrichtung
ATE449849T1 (de) Ob rezeptor-variante und liganden
AU8729101A (en) Combined use of anti-cytokine antibodies or antagonists and anti-CD20 for the treatment of B cell lymphoma
DE69832657D1 (de) Empfangseinrichtungen und Empfangsverfahren
DE69835254D1 (de) Empfangseinrichtungen und Empfangsverfahren
DE69833909D1 (de) Lasthalteanordnung und Haltegerät
NO975976D0 (no) Vitronektinreseptor-antagonister, fremstilling samt anvendelse derav
ATE227724T1 (de) Muscarinagonisten und antagonisten
DE69831750D1 (de) Biozide und biozide tücher
DE59903751D1 (de) 2',2'-difluornucleoside zur immunosuppressiven therapie und kombinationspräparate
NO20004274D0 (no) Proteaseaktivert reseptor 4 og anvendelse derav
ATE368742T1 (de) Aminoterminalen verkürzten c-c chemokine und als chemokine antagonist
TR199701645A3 (tr) Vitronektin reseptör antagonistleri,bunlarin imalati ve kullanimi
DE60004989D1 (de) Fluoroalkansulfonylazid-monomere und copolymere davon
CZ2000522A3 (cs) Farmaceutický prostředek na bázi piperidinalkanolového antihistaminika a použití
GB9820014D0 (en) Receptor antagonists and uses thereof
ATE227582T1 (de) Chemokin rezeptor antagonist und cyclosporin in kombinationstherapie
DE60016963D1 (de) Polyimidcopolymer und metallverbundstoff dieses enthaltend
PL363048A1 (en) Azabicyclic derivatives and their therapeutic use
DE69932577D1 (de) Stangenbehandlungsgerät und Stangenladegerät
ZA981782B (en) The use of levobupivacaine in combination with other drugs
MA26894A1 (fr) Agents antihypertenseurs et leur utilisation
HU0000744D0 (en) Transposing unit and flaw

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1113811

Country of ref document: EP

EEFA Change of the company name